Abdelali Agouni

Prof. Dr. Abdelali Agouni

Qatar University
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in The American Journal of Pathology
Verified
Journal Article
Closed access
AAAbdelali Agouni
Abdelali Agouni
ALAnne Hélène Lagrue-Lak-Hal
Anne Hélène Lagrue-Lak-Hal
PDPierre Henri Ducluzeau
Pierre Henri Ducluzeau
HMHadj Ahmed Mostefai
Hadj Ahmed Mostefai
CDCatherine Draunet-Busson
Catherine Draunet-Busson
RARamaroson Andriantsitohaina
Ramaroson Andriantsitohaina

1 December 2008 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
HMHadj Ahmed Mostefai
Hadj Ahmed Mostefai
FMFerhat Meziani
Ferhat Meziani
MMMaria Letizia Mastronardi
Maria Letizia Mastronardi
AAAbdelali Agouni
Abdelali Agouni
CHChristophe Heymes
Christophe Heymes
RARamaroson Andriantsitohaina
Ramaroson Andriantsitohaina
Rationale: Sepsis is an archetypal condition with molecular links between inflammation and coagulation. Both events can be orchestrated by the interaction between circulating and vascular cells that under activation release microparticles. Objectives: We characterized circulating microparticles from both nonseptic subjects and patients with septic shock and evaluated their contribution to vascular function. Methods: Circulating microparticles and their cell origin were measured in blood from 36 patients with septic shock and 18 nonseptic subjects by flow cytometry. Microparticles were then injected intravenously into mice and vascular reactivity was assessed in aorta. Expression and activity of enzymes involved in nitric oxide (NO) and cyclooxygenase metabolite production were analyzed. Measurements and Main Results: Circulating levels of microparticles and platelet- and endothelial-derived microparticles were increased in septic patients. Surprisingly, septic microparticles enhanced the sensitivity of contraction of mouse aorta in response to serotonin. Interestingly, septic microparticles enhanced the contraction of aorta from lipopolysaccharide-treated mice. This effect was linked neither to increased calcium entry nor to Rho kinase inhibitor–sensitive mechanisms. In addition, the effect of septic microparticles was not modified either by NO-synthase or cyclooxygenase-2 inhibitors, and was not associated with NO or O2− overproduction. The nonselective cyclooxygenase-2 inhibitor indomethacin reduced, and the specific thromboxane A2 antagonist SQ-29548 abolished, aortic contraction in mice treated with nonseptic and septic microparticles. The effect of septic microparticles was associated with increased thromboxane A2 production, and was sensitive to a selective thromboxane A2 antagonist. Conclusions: We provide evidence that increased circulating microparticles are protective against vascular hyporeactivity accounting for hypotension in patients with septic shock.

11 April 2007 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
AAAbdelali Agouni
Abdelali Agouni
HMH. Ahmed Mostefai
H. Ahmed Mostefai
Chiara PorroChiara Porro
Chiara Porro
NCNunzia Carusio
Nunzia Carusio
JFJulie Favre
Julie Favre
RARamaroson Andriantsitohaina
Ramaroson Andriantsitohaina
Microparticles (MPs) are small fragments generated from the plasma membrane after cell stimulation. Among the candidate proteins harbored by MPs, we recently showed that sonic hedgehog (Shh) is present in MPs generated from activated/apoptotic human T lymphocytes [Martinez et al., Blood (2006) vol. 108, 3012–3020]. We show here that Shh carried by MPs induces nitric oxide (NO) release from endothe‐lial cells, triggers changes in the expression and phos‐phorylation of enzymes related to the NO pathway, and decreases production of reactive oxygen species. When PI3‐kinase and ERK signaling were specifically inhibited, the effects of MPs were reversed. In vivo injection of MPs in mice was also able to improve endothelial function by increasing NO release, and it reversed endothelial dysfunction after ischemia/reperfusion. Silencing the effects of Shh with cyclopamine, a specific inhibitor of Shh, or siRNA, an inhibitor of the Shh receptor Patched, strongly reduced production of NO elicited by MPs. Taken together, we propose that the biological message carried by MPs harboring Shh may represent a new therapeutic approach against endothe‐lial dysfunction during acute severe endothelial injury.—Agouni A., Mostefai, H. A., Porro, C., Carusio, N., Favre, J., Richard, V., Henrion, D., Martinez, M. C., Andriantsitohaina R. Sonic hedgehog carried by micro‐particles corrects endothelial injury through nitric oxide release. FASEB J. 21, 2735–2741 (2007)

15 May 2006 in Cancer Research
Verified
Journal Article
Open access
PDF file
CSCarole Sourbier
Carole Sourbier
VLVérOnique Lindner
VérOnique Lindner
HLHervé Lang
Hervé Lang
AAAbdelali Agouni
Abdelali Agouni
ESEric Schordan
Eric Schordan
TMThierry Massfelder
Thierry Massfelder
Metastatic renal cell carcinoma is resistant to current therapies. The phosphoinositide 3-kinase (PI3K)/Akt signaling cascade induces cell growth, cell transformation, and neovascularization. We evaluated whether targeting this pathway could be of therapeutic value against human renal cell carcinoma. The activation of the PI3K/Akt pathway and its role in renal cell carcinoma progression was evaluated in vitro in seven human cell lines by Western blot, cell counting, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, terminal deoxyribonucleotide transferase–mediated nick-end labeling assays, and fluorescence-activated cell sorting analysis, using two PI3K inhibitors, LY294002 and wortmannin, as well as by transfection with various Akt constructs and through Akt knockdown by small interfering RNA (siRNA). In vivo nude mice bearing human renal cell carcinoma tumor xenografts were treated with LY294002 (75 mg/kg/wk, 4 weeks, i.p.). Tumor growth was measured and tumors were subjected to Western blot and immunohistochemical analysis. Akt was constitutively activated in all cell lines. Constitutive phosphorylation of glycogen synthase kinase-3 (GSK-3) was observed in all cell lines, whereas forkhead transcription factor and mammalian target of rapamycin, although expressed, were not constitutively phosphorylated. Exposure to LY294002 or wortmannin decreased Akt activation and GSK-3 phosphorylation and reduced cell growth by up to 70% through induction of cell apoptosis. These effects were confirmed by transfection experiments with Akt constructs or Akt siRNA. Importantly, LY294002 induced up to 50% tumor regression in mice through tumor cell apoptosis. Tumor neovascularization was significantly increased by LY294002 treatment. Blood chemistries showed no adverse effects of the treatment. Our results suggest an important role of PI3K/Akt inhibitors as a potentially useful treatment for patients with renal cell carcinoma. (Cancer Res 2006; 66(10): 5130-42)

12 August 2011 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
AAAbdelali Agouni
Abdelali Agouni
NMNimesh Mody
Nimesh Mody
COCarl Owen
Carl Owen
ACAlicja Czopek
Alicja Czopek
DZDerek Zimmer
Derek Zimmer
MDMirela Delibegović
Mirela Delibegović
Obesity is associated with induction of the ER (endoplasmic reticulum)-stress response signalling and insulin resistance. PTP1B (protein tyrosine phosphatase 1B) is a major regulator of adiposity and insulin sensitivity. The aim of the present study was to investigate the role of L-PTP1B (liver-specific PTP1B) in chronically HFD (high-fat diet) and pharmacologically induced (tunicamycin and thapsigargin) ER-stress response signalling in vitro and in vivo. We assessed the effects of ER-stress response induction on hepatic PTP1B expression, and consequences of hepatic-PTP1B deficiency, in cells and mouse liver, on components of ER-stress response signalling. We found that PTP1B protein and mRNA expression levels were up-regulated in response to acute and/or chronic ER stress, in vitro and in vivo. Silencing PTP1B in hepatic cell lines or mouse liver (L-PTP1B−/−) protected against induction of pharmacologically induced and/or obesity-induced ER stress. The HFD-induced increase in CHOP (CCAAT/enhancer-binding protein homologous protein) and BIP (binding immunoglobulin protein) mRNA levels were partially inhibited, whereas ATF4 (activated transcription factor 4), GADD34 (growth-arrest and DNA-damage-inducible protein 34), GRP94 (glucose-regulated protein 94), ERDJ4 (ER-localized DnaJ homologue) mRNAs and ATF6 protein cleavage were completely suppressed in L-PTP1B−/− mice relative to control littermates. L-PTP1B−/− mice also had increased nuclear translocation of spliced XBP-1 (X box-binding protein-1) via increased p85α binding. We demonstrate that the ER-stress response and L-PTP1B expression are interlinked in obesity- and pharmacologically induced ER stress and this may be one of the mechanisms behind improved insulin sensitivity and lower lipid accumulation in L-PTP1B−/− mice.

11 February 2019 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
HMHatem Maamoun
Hatem Maamoun
TBTarek Benameur
Tarek Benameur
Gianfranco PintusGianfranco Pintus
Gianfranco Pintus
Shankar MunusamyShankar Munusamy
Shankar Munusamy
AAAbdelali Agouni
Abdelali Agouni
Type-2 diabetes prevalence is continuing to rise worldwide due to physical inactivity and obesity epidemic. Diabetes and fluctuations of blood sugar are related to multiple micro- and macrovascular complications, that are attributed to oxidative stress, endoplasmic reticulum (ER) activation and inflammatory processes, which lead to endothelial dysfunction characterized, among other features, by reduced availability of nitric oxide (NO) and aberrant angiogenic capacity. Several enzymatic anti-oxidant and anti-inflammatory agents have been found to play protective roles against oxidative stress and its downstream signaling pathways. Of particular interest, heme oxygenase (HO) isoforms, specifically HO-1, have attracted much attention as major cytoprotective players in conditions associated with inflammation and oxidative stress. HO operates as a key rate-limiting enzyme in the process of degradation of the iron-containing molecule, heme, yielding the following byproducts: carbon monoxide (CO), iron, and biliverdin. Because HO-1 induction was linked to pro-oxidant states, it has been regarded as a marker of oxidative stress; however, accumulating evidence has established multiple cytoprotective roles of the enzyme in metabolic and cardiovascular disorders. The cytoprotective effects of HO-1 depend on several cellular mechanisms including the generation of bilirubin, an anti-oxidant molecule, from the degradation of heme; the induction of ferritin, a strong chelator of free iron; and the release of CO, that displays multiple anti-inflammatory and anti-apoptotic actions. The current review article describes the major molecular mechanisms contributing to endothelial dysfunction and altered angiogenesis in diabetes with a special focus on the interplay between oxidative stress and ER stress response. The review summarizes the key cytoprotective roles of HO-1 against hyperglycemia-induced endothelial dysfunction and aberrant angiogenesis and discusses the major underlying cellular mechanisms associated with its protective effects.